| Code | 4029E | ||||||||||
| MA number | 07/0178/23-S | ||||||||||
| Product Form: | tbl eff 20(2x10)x500 mg/200 mg/4 mg (tuba PP) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 07 - ANALGETICA, ANTIPYRETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | tube polypropylene | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 11.08.2023 |
| Validity: | 11.08.2028 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Dehorsan 500 mg_200 mg_4 mg šumivé tablety_08_2023.pdf
|
| SPC: |
SPC_Dehorsan 500 mg_200 mg_4 mg šumivé tablety_08_2023.pdf
|
| Safety feature | No |
| Data update: | 14.08.2023 |
